SC 13D

Company

Indivior Pharmaceuticals, Inc.

Filed

October 4, 2024

Accession Number

0001140361-24-042795

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →